Safety and immunogenicity of heterologous ChAdOx1-nCoV19 and BNT162b2 vaccination: A meta-analysis of the heterologous COVID-19 vaccination outcomes

INTRODUCTION: Here, we systematically assessed the safety and immunogenicity of the heterologous ChAd/BNT vaccination regimens. MATERIALS AND METHODS: We evaluated the immunogenicity by the geometric mean titers ratio (GMTR) of the neutralizing antibody and anti-spike IgG. The safety of heterologous...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yuxuan, Wang, Yanning, Shao, Taihang, Tang, Wenxi, Hu, Kerong, Zhou, Yujie, Miao, Liyun, Liu, Jing, Wang, Bin, Yu, Wenying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060199/
https://www.ncbi.nlm.nih.gov/pubmed/37037708
http://dx.doi.org/10.1016/j.vaccine.2023.03.056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060199/
https://www.ncbi.nlm.nih.gov/pubmed/37037708
http://dx.doi.org/10.1016/j.vaccine.2023.03.056

Ejemplares similares